坪田ラボ – Tsubota-Lab

イノベーションで、世界をごきげんに、健康にする

Through innovation in health and medical fields,
we will make the world happier and healthier.

坪田ラボは"ごきげん"をキーワードに近視、ドライアイ、老眼に革新的なソリューションを
開発する慶應大学発ベンチャーである。

健康、医療分野のイノベーションを通して世界をよりごきげんに、健康にしたい。サイエンスに基づいた革新的な医薬品、サプリメント、医療器具、健康グッズの開発を通してパートナー企業の可能性を拓いていきたい。

Tsubota Laboratory, a startup from Keio University, develops innovative solutions for myopia, dry eyes and presbyopia.

Through innovation in health and medical fields, we will make the world happier and healthier.
We will expand the possibility of our partner companies by revolutionary medicine, supplements, medical devices and health products that are developed based on science.

これまでになかったドライアイ対策を!

ドライアイ研究で世界を牽引してきた知見に基づき、イノベーティブな対症方法、予防法、さらにはデバイスの開発に取り組んでいます。基礎研究から臨床研究試験を経たエビデンスに支えられたサプリメントや、診断に役立つツールなどを開発し、さらに、関連特許の取得を目指した目を潤す新たな医療機器の開発など、チャレンジは続きます。

Development of Innovative Treatment for Dry Eye

Based on the knowledge of our Founding Scientist, Prof. Kazuo Tsubota, we are working on the development of innovative treatment, prevention and medical devices on dry eyes. An evidence-based dietary supplement for prevention and also simple diagnostic tools have been developed. Our challenges continue to develop a patent-pending novel medical device to moisten the eyes.

子供を近視からまもろう！

世界で増え続ける近視人口を止めるため、バイオレットライト仮説に基づく新しいアプローチで研究を進めています。私たちの夢は近視の予防法が確立され、治療法が臨床応用され、多くの子供たちを近視からまもることです。医学的アプローチ以外でも、ライフスタイルの中にも近視を悪化させる要素があると考え、これらに対するエビデンスに基づいたソリューション開発に取り組んでいます。近視は失明のリスクにもなる疾患です。多くの子供たちを近視から守り、快適で健康な視力を多くの人に届けたいと考えています。

Myopia Prevention for Kids!

To stop the global increase of myopia, we are doing research on a novel violet light theory. Our dream is to protect children from myopia through our new myopia prevention method and clinical applications. Besides medical approaches, we believe there exist factors in our lifestyle to worsen myopia, for which we will offer evidence based solutions. Myopia is a risk factor for blindness. Our hope is to protect kids from myopia and offer the healthy vision life.

老眼に新たな治療法を！

老眼はエイジングの始まりのサインともとらえられます。これまでは、老眼は誰もが避けられない目の加齢現象であると考えられ、老眼鏡での対処が主でした。私たちは、むしろ老眼は全身の老化のサインと考え、抗酸化物質などでの予防や、老眼を引き起こすと考えられる水晶体の固さの度合いなどの計測技術の開発などを手がけています。

Innovative Solutions for Presbyopia

Presbyopia can be considered as a sign of aging, not only in eyes but the entire body. It has been thought inevitable under the aging process, and the most common solution that clinicians provide is still “reading glasses”. We are developing anti-oxidant supplement for prevention, as well as measurement techniques for the stiffness of crystalline lens.

Related Papers

Katada Y, Negishi K(*CO), Watanabe K, Shigeno Y, Saiki M, Torii H, Kaido M, Tsubota K

Tsuneyoshi Y, Negishi K, Saiki M, Toda I, Tsubota K.

Tsuneyoshi Y, Negishi K, Tsubota K.

15.Nov.2019: 特許庁の2019年度「知財アクセラレーションプログラムIPAS2019」に選ばれました！

We were selected as a participant in the "IP Acceleration program for Startups (IPAS)" of Japan Patent Office for this fiscal year.

06.Nov.2019: 湖北省・国際イノベーションコンファレンスビジネスコンテストで「近視進行抑制の研究と事業展開」にて3位を受賞しました。

We won the third prize in the "2019 International Science and Technology Innovation and Entrepreneurship Competition" held in Wuhan, Hubei Province, China. The participants were startups from the US, UK, Japan, France, Canada and Singapore, and presented their new technologies and business models.

05.Nov.2019: NEDOの2019年度「研究開発型ベンチャー支援事業／シード期の研究開発型ベンチャーに対する事業化支援」の事業者に選ばれました！

We were selected as a recipient of a NEDO grant for Seed-stage Technology-based Startups (STS) for this fiscal year.

03.Nov.2019: NHK「近視クライシス」に出演

“Myopia Crisis” featured on NHK Broadcasting

10.Sep.2019: 中小機構の令和元年度「戦略的知財活用海外展開補助金」を獲得しました！

We were selected as a recipient of the "Strategic IP Overseas Expansion Grant" of Organization for Small & Medium Enterprises and Regional Innovation, Japan for this fiscal year.

30.Aug.2019: 現在、6～12歳（小学校1年生～6年生）の方で、近視と診断された方を対象としたメガネ型医療機器の治験を実施しています。※治験参加者の募集は終了いたしました。

We are conducting a clinical trial with our eyeglasses-type medical device for myopic grade school children aged from 6 to 12.

17.Aug.2019: 慶大眼科より日本の小中学生の近視増加に関する論文を発表しました。

The paper on current prevalence on myopia was published on JAMA OPHTHALMOLOGY.

09.Aug.2019: 慶大眼科よりクロセチンが児童の近視進行を抑制することに関する論文を発表しました。

The paper on the effects of crocetin on myopia suppression in children was published on Journal of Clinical Medicine.

30.Jul.2019: KEIO RESEACH HIGHLIGHTSで近視研究が紹介されました。

Prof. Tsubota’s was interviewed by KEIO RESEACH HIGHLIGHTS.

30.May.2019: 近視進行抑制に効果のあるメガネを開発し、現在治験を実施中。(特許第6085722号；特許第6175210号)

Myopia Suppression Glasses are under clinical trial (patents pending: JP6085722、WO/2015/186723；JP6175210、WO/2017/94886)

28.Feb.2019: 坪田一男が代表取締役に就任しました。

Dr Kazuo Tsubota was appotined as CEO.

23.Jan.2019: 近視とクロセチンに関する論文を発表しました。

The paper on crocetin and myopia was published.

01.Nov.2018: Ultrasonic Moisture Glassesに関する論文を発表しました。

Our paper titled, "Effect of Ultrasonic Moisture Glasses on Dry Eye Signs and Symptoms” was published.

01.Oct.2018: 2018年10月10日(水)~12日(金) Japan Healthcare Venture Summit 2018へ出展し、弊社CTO近藤がピッチセッションに登壇しました。

We joined Japan Healthcare Venture Summit 2018 and our CTO, Dr. Kondo gave a talk in a pitch session.

01.Sep.2018: BALMUDA The Light：開発に伴い、目の負担を軽減する効果に関する臨床研究を実施しました

A clinical test was conducted with BALMUDA for the possible effect of decreasing eye fatigue, especially for children.

12.Mar.2018: テレビ東京日経スペシャル「カンブリア宮殿」に3月22日（木）夜10時ーに出演します。

Prof Tsubota is on TV show, named “ Ryu’s Talking Live by TV Tokyo on March 22, starting at 10pm.

14.Aug.2017: TBSテレビ「人間とは何だ」坪田がアジアでの近視人口の増加や近視パンデミックについて解説いたしました

Prof Tsubota was on the TV show by Tokyo Broadcasting Systems

01.Feb.2017: ディスカバー21より「あなたのこども、そのままだと近視になリます」出版

Publication of Prof. Tsubota’s new book, “Myopia Prevention for Kids”.

19.Jan.2017: NHK「あさイチ」坪田が近視の最新研究について解説

Prof. Tsubota’s appearance on the NHK morning show to talk about the latest Myopia research.

26.Dec.2016: 現代社会に欠如しているバイオレットライトが近視進行を抑制することを発見－近視進行抑制に紫の光－論文発表とプレスリリース

Press release on the publication of new research by the Keio group, “Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression”

15.Nov.2019: We were selected as a participant in the "IP Acceleration program for Startups (IPAS)" of Japan Patent Office for this fiscal year.

06.Nov.2019: We won the third prize in the "2019 International Science and Technology Innovation and Entrepreneurship Competition" held in Wuhan, Hubei Province, China. The participants were startups from the US, UK, Japan, France, Canada and Singapore, and presented their new technologies and business models.

05.Nov.2019: We were selected as a recipient of a NEDO grant for Seed-stage Technology-based Startups (STS) for this fiscal year.

03.Nov.2019: “Myopia Crisis” featured on NHK Broadcasting

10.Sep.2019: We were selected as a recipient of the "Strategic IP Overseas Expansion Grant" of Organization for Small & Medium Enterprises and Regional Innovation, Japan for this fiscal year.

30.Aug.2019: We are conducting a clinical trial with our eyeglasses-type medical device for myopic grade school children aged from 6 to 12.

17.Aug.2019: The paper on current prevalence on myopia was published on JAMA OPHTHALMOLOGY.

09.Aug.2019: The paper on the effects of crocetin on myopia suppression in children was published on Journal of Clinical Medicine.

30.Jul.2019: Prof. Tsubota’s was interviewed by KEIO RESEACH HIGHLIGHTS.

30.May.2019: Myopia Suppression Glasses are under clinical trial (patents pending: JP6085722、WO/2015/186723；JP6175210、WO/2017/94886)

28.Feb.2019: Dr Kazuo Tsubota was appotined as CEO.

23.Jan.2019: The paper on crocetin and myopia was published.

01.Nov.2018: Our paper titled, "Effect of Ultrasonic Moisture Glasses on Dry Eye Signs and Symptoms” was published.

01.Oct.2018: We joined Japan Healthcare Venture Summit 2018 and our CTO, Dr. Kondo gave a talk in a pitch session.

01.Sep.2018: A clinical test was conducted with BALMUDA for the possible effect of decreasing eye fatigue, especially for children.

12.Mar.2018: Prof Tsubota is on TV show, named “ Ryu’s Talking Live by TV Tokyo on March 22, starting at 10pm.

14.Aug.2017: Prof Tsubota was on the TV show by Tokyo Broadcasting Systems

01.Feb.2017: Publication of Prof. Tsubota’s new book, “Myopia Prevention for Kids”.

19.Jan.2017: Prof. Tsubota’s appearance on the NHK morning show to talk about the latest Myopia research.

26.Dec.2016: Press release on the publication of new research by the Keio group, “Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression”

眼科医坪田一男 オフィシャルサイト Kazuo Tsubota Official Site

慶應義塾大学医学部 眼科学教室 Dept. of Ophthalmology Keio Univ.

ドライアイ研究会 DRY EYE SOCIETY

近視研究会 Myopia Society Japan

会社名：: 株式会社坪田ラボ
設立日：: 2015年2月19日
資本金：: 201,553,000円
創業科学者・: 　
代表取締役社長：: 坪田一男
　: （慶應義塾大学医学部眼科学教室教授）
住所：: 〒160-8582　東京都新宿区信濃町35番地
　: 慶応義塾大学信濃町キャンパス2-5フロア
電話：: 03-6384-2866

COMPANY：: Tsubota Laboratory, Inc.
Founded：: February 19th 2015
Paid-in Capital：: 201,553,000 yen
Founding Scientist・: 　
CEO：: Kazuo Tsubota
Professor in Department of Ophthalmology, Keio University School of Medicine
Address：: Keio University
Shinanomachi Campus 2-5 Floor
35 Shinanomachi
Shinjuku-ku, Tokyo 160-8582
JAPAN
Phone：: +81-3-6384-2866